2型糖尿病患者20分钟动态多参数全身[18F]FDG PET/CT定量器官与组织摄取的重测重复性
研究纳入15例2型糖尿病患者,连续两天禁食6小时后行20分钟[18F]FDG动态全身PET/CT,重建注射后60-80分钟的SUV与MRFDG图像。结果显示所有测量器官SUVmean与MRFDG-mean的ICC分别为0.65-0.95和0.66-0.94,SUVmean的可靠性一般高于MRFDG-mean,但多数组织MRFDG重测变异<19%,作者认为MRFDG可作为治疗反应的精确标志物。
要点
- 15例2型糖尿病患者连续两天行20分钟[18F]FDG动态全身PET/CT,评估SUV与MRFDG重测重复性。
- 所有测量器官SUVmean的ICC为0.65-0.95,MRFDG-mean的ICC为0.66-0.94。
- 多数分析组织MRFDG重测变异<19%,作者认为其可作为治疗反应的精确标志物。
核心结论
- 动态全身PET/CT计算的MRFDG在2型糖尿病患者多数器官中表现出高重复性,与SUV相当。
研究设计与样本
- 15例2型糖尿病患者(平均年龄71±7岁,女性2例)连续两天禁食6小时后行20分钟[18F]FDG动态全身PET/CT。
- SUV与MRFDG图像均从注射后60-80分钟获取的动态全身PET/CT数据重建。
- 在器官和组织中测量MRFDG与SUV数据,采用Bland-Altman分析、组内相关系数(ICC)、重复性系数(RPC)和变异系数(wCV)评估重复性。
主要发现
- 所有测量器官SUVmean的ICC范围为0.65-0.95,MRFDG-mean的ICC范围为0.66-0.94。
- 与MRFDG-mean相比,SUVmean通常表现出更高的可靠性(ICC)和更低的变异性(%RPC和%wCV)。
- 多数分析组织的MRFDG重测变异<19%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently developed dynamic whole-body PET/CT (D-WB PET/CT) protocols allow for measurements of potentially more precise metabolic parameters than the commonly used semiquantitative SUV. Most notable is the metabolic rate of FDG uptake (MRFDG), which reflects quantitative glucose uptake into tissues and organs. However, data on the reproducibility of MRFDG measurements are scarce, particularly in patients with perturbed glucose homeostasis such as type 2 diabetes. We therefore aimed to evaluate the test-retest repeatability of both MRFDG and SUV in these patients. RESULTS: Fifteen participants (mean age 71 ± 7 years; 2 females) with type 2 diabetes underwent a short 20-minute [18F]FDG D-WB PET/CT after 6 h fasting on two consecutive days. Both SUV and MRFDG images were reconstructed from D-WB PET/CT data obtained 60-80 min post-injection of [18F]FDG. MRFDG and SUV data were measured in organs and tissues, and repeatability was assessed with Bland-Altman analysis, intraclass correlation coefficients (ICC), repeatability coefficients (RPC) and coefficients of variation (wCV). There was high repeatability of both SUVmean and MRFDG-mean in all measured organs (ICC range: 0.65-0.95 for SUVmean and 0.66-0.94 for MRFDG-mean). SUVmean generally demonstrated higher reliability (ICC) and lower variability (%RPC and %wCV) when compared to MRFDG-mean. However, MRFDG test-retest variation was < 19% in most analysed tissues, demonstrating that MRFDG may be used as a precise marker of treatment response. CONCLUSION: This study demonstrates that MRFDG calculated from D-WB PET/CT exhibit high repeatability, comparable to SUVs across most organs in patients with type 2 diabetes.
引用
- Baier JM, Funck KL, Dons-Jensen A, et al. Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes. EJNMMI Res. 2025. PMID: 40354003. doi:10.1186/s13550-025-01249-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。